Andreessen Horowitz: Raises Third $750M Bio Fund
- Menlo Park, CA-based venture capital firm Andreessen Horowitz raised $750M for its third bio fund
- Andreessen Horowitz’s previous biotech and health care funds came in at $450 million for Bio Fund II
- The firm’s portfolio companies are operating on several sides of this emerging sector
- Take Devoted Health as an example. It’s a broker of Medicare Advantage plans
- Andreessen Horowitz led the company’s $300 million Series B round in October 2018
- More recent additions to the portfolio also include cancer drug company Erasca and The One Health Company
- Then the new fund follows the first bio fund which, launched in 2015, amounted to $200m
